Sage Therapeutics, Inc. - COM (SAGE)

Q2 2017 13F Holders as of 6/30/2017

Type / Class
Equity / COM
Number of holders
187
Total Shares
38.4M
Shares change
+604K
Total reported value, excl. options
$3.06B
Value change
+$50.7M
Put/Call ratio
0.79
Number of buys
86
Number of sells
-94
Price
$79.64
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.